An increasing trend of clinical trials is evaluating SGLT2is as primary prevention rather than treatment.
← all excerpts
Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Kidney Disease and beyond.
1
—
—
An increasing trend of clinical trials is evaluating SGLT2is as primary prevention rather than treatment.